Bemarinone

This classification denotes a cardiotonic agent with the molecular formula C11H12N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29J330V3XV, chemically known as 2(1h)-quinazolinone, 5,6-dimethoxy-4-methyl- but generally known as bemarinone, which bears US NIH Compound Identifier 58575. Bemarinone most often comes in base and hydrochloride forms. European Medicines Agency schedules Bemarinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05690MIG. The term BEMARINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). BEMARINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bemarinone under HS 29335995 and SITC 51576. As of Q4 2014, BEMARINONE remains the US FDA Preferred Term for this commodity. Bemarinone bears US NLM identifiers UMLS ID C0634220 and NCI Concept Code C76025. SMILES: CC1=C2C(=NC(=O)N1)C=CC(=C2OC)OC.